Generic Drug Producers Have $45 Billion Opportunity

Generic drug producers have been handed windfall sales over the past decade. According to a new report from Morgan Stanley on the state of the generic drug industry published this week, $160 billion to $170 billion of branded sales have lost patent protection over the last ten years, and generic producers have been quick to take advantage.  HHS Secretary Calls for Price Controls on Some Prescription Drugs War on Drugs Has Cost America Over $1 Trillion [INFOGRAPHIC] This trend is expected to continue with roughly $80 billion in branded sales projected to lose patent protection over the next five years….